Xilio Therapeutics shares owned by UBS Group
Historical chart of UBS Group investment in Xilio Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Xilio Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Xilio Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $238k | 249k | 0.96 |
| 2024-09-30 | $12k | 16k | 0.79 |
| 2024-06-30 | $190 | 201 | 0.95 |
| 2024-03-31 | $216 | 201 | 1.08 |
| 2023-12-31 | $110 | 201 | 0.55 |
| 2023-09-30 | $424 | 201 | 2.11 |
| 2023-06-30 | $527 | 201 | 2.62 |
| 2023-03-31 | $637 | 201 | 3.17 |
| 2022-12-31 | $540 | 201 | 2.69 |
| 2022-09-30 | $999 | 201 | 4.98 |
| 2022-06-30 | $14k | 2.8k | 4.98 |
| 2022-03-31 | $7.0k | 964 | 7.26 |
| 2021-12-31 | $64k | 4.0k | 16.09 |